
Journal of Medicinal Chemistry p. 456 - 461 (1989)
Update date:2022-08-02
Topics:
Laduree, Daniel
Lancelot, Jean-Charles
Robba, Max
Chenu, E.
Mathe, G.
Treatment of N-(2-furoyl)proline (1a) or N-thenoylprolines (1b, 1c) and N-(2-thenoyl)thiazolidine-4-carboxylic acid (1d) with acetic anhydride and dimethyl acetylenedicarboxylate gave 5-substituted derivatives of dimethyl 2,3-dihydro-1H-pyrrolizine-6,7-dicarboxylate (2a, 2b, 2c) and derivatives of dimethyl 5-(2-thienyl)pyrrolo<1,2-c>thiazole (2d).Reduction of 2 with lithium aluminum hydride gave the diols 3a, 3b, 3c, and 3d.These diols yielded the corresponding diacetates 4 by treatment with acetic anhydride.The bis(methylcarbamates) 5a, 5b, 5c, and 5d and bis(isopropylcarbamates) 6b and 6c are obtained with the appropiate isocyanates.The 1-substituted pyrrolizines were synthesized, the 1-acetoxy compounds 7b and 7c further transformed into 1-hydroxy (8b, 8c) and 1-oxo (9b, 9c) analogues.The action of hydrochloric acid on 1-acetoxy derivatives (7b, 7c) gave 3H-pyrrolizines (10b, 10c).Evaluation of antileukemic activity was investigated on the leukemia L1210 in vivo, on several bis(alkylcarbamates).The compounds 5c and 5d show good antileukemic activity comparable with the mitomycin.
View MoreContact:+86 755 26588093
Address:No.9 Linkong West Street, Hengdian Street, Huangpi District, Wuhan City, China.
Shandong united-rising pharmaceutical cooperation.,ltd.
Contact:008653187965009
Address:171No., Jing5 Road, Shizhong District, Jinan, China
Hubei Lansun Biochemical Pharmaceutical Co., Ltd
Contact:714-6395977
Address:No. 81 Pengcheng Avenue, economic and technological development zone, Huangshi City, Hubei Province,China
Yixing Zhenfen Medical Chemical Co.Ltd
Contact:86-510-87552708
Address:Fenshui ,Yixing city,Jiangsu
Taizhou Elitechemie MediPharma Technology Co.,Ltd.
Contact:+86-523-86810021
Address:Building G14,NO.1 Avenue,China Medical City, Taizhou, Jiangsu,China
Doi:10.1021/ol901125n
(2009)Doi:10.1002/chem.201200279
(2012)Doi:10.1039/b901631g
(2009)Doi:10.1002/1522-2675(200208)85:8<2559::AID-HLCA2559>3.0.CO;2-9
(2002)Doi:10.1016/j.bmcl.2015.11.047
(2016)Doi:10.1002/adsc.200800584
(2009)